Australian Licences received
PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com
FOR PUBLIC RELEASE
NZX Limited
Wellington
26
th
June 2023
Wholesale Licences received in Australia.
Rua Bioscience has received the required Licences to begin wholesale and trade activities of Rua branded
medicinal cannabis products in Australia. In conjunction with its distributor in Australia, Rua plans to launch a
range of products in Australia in Q3 2023.
Paul Naske, CEO of Rua Bioscience said, “We are excited about the prospect of launching in the Australian market.
Our preferential supply agreement with Cann Group in Australia means we are very well placed to be able to grow
our revenue in Australia.”
Medicinal cannabis in Australia was legalised in 2016 with a regulatory regime that has allowed for significant
market growth. The market in calendar year 2022 was estimated to be A$240 million and it is still showing signs
of very strong growth.
1
Between H1 2022 and H2 2022 the number of units of medicinal cannabis products
prescribed increased by 41%. This same data suggests a very conservative estimate of volume for the dried
flower market last year was 13,000kg which does not include volume grown for other formulated products.
This launch of product into the Australian market follows closely on from our first exports into the German
market. It’s an exciting period in Rua’s journey. Rua’s strategy of working with a network of supply partners and
establishing pipelines of product in export markets is capital light. This allows the business to scale considerably,
in-turn returning value to the shareholders and community of Tairawhiti.
For more information about Rua Bioscience please visit www.ruabioscience.com.
ENDS
The person who authorised this announcement:
Paul Naske,
Chief Executive Officer
For shareholder enquiries please visit www.ruabio.com or contact:
info@ruabio.com
0800 RUABIO
Source:
1 - Pennington Institute Australia, May 2023 https://www.youtube.com/watch?v=3FtzL4QerCM
MARKET ANNOUNCEMENT
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.